氨甲环酸可有效降低青少年脊柱侧凸手术中的失血速率:一项随机安慰剂对照试验
这项前瞻性双盲随机安慰剂对照试验纳入111例青少年特发性脊柱侧凸患者,比较氨甲环酸(TXA,50 mg/kg负荷剂量及10 mg/kg/h输注)与安慰剂的失血情况。TXA组术中失血量较安慰剂组减少27%,每小时失血速率、每融合节段失血速率及术后引流量均显著降低,安慰剂组有6例需异体输血而TXA组无。
要点
- TXA组术中失血量较安慰剂组减少27%,每小时失血速率190±73 vs 230±80 mL(p=0.01)。
- 临床相关失血(>20 mL/kg)风险安慰剂组为44%,TXA组为21%,相对风险=2.1(95%CI 1.2至3.7)。
- 安慰剂组6例需异体输血,TXA组无;未见血栓栓塞事件或癫痫发作等围手术期不良事件。
核心结论
- 青少年特发性脊柱侧凸手术中使用TXA较安慰剂显著减少失血量27%。
- TXA组每小时术中失血速率、每融合节段失血速率及术后失血量均显著低于安慰剂组。
- 安慰剂组接受异体输血的患者更多;术中失血量更大者住院时间更长。
研究设计与样本
- 经机构审查委员会批准的前瞻性双盲随机安慰剂对照试验,纳入111例青少年特发性脊柱侧凸患者。
- 患者随机接受安慰剂或TXA(50-mg/kg负荷剂量及10-mg/kg/h输注)。
- 功效分析表明每组50例可检测失血量>20%的差异;采用双因素方差分析(ANOVA)通过组×时间交互F检验比较失血速率(斜率)。
主要发现
- 临床相关失血(>20 mL/kg)风险安慰剂组为44%,TXA组为21%,相对风险=2.1(95%CI 1.2至3.7)。
- TXA组较安慰剂组术中失血量减少27%;每小时术中失血速率190±73 vs 230±80 mL(p=0.01;F=9.77,p<0.001)。
- 每融合节段失血速率82±32 vs 110±40 mL(p<0.001);术中失血量836±373 vs 1,031±484 mL(p=0.02)。
- 术后引流量498±228 vs 645±318 mL(p=0.009);安慰剂组6例需异体输血,TXA组0例。
- 预测失血的三个独立因素为TXA给药、手术时长和融合节段数;术中失血量更大是住院时间延长的唯一独立预测变量。
关键数值与推荐
- TXA方案为50-mg/kg负荷剂量及10-mg/kg/h输注。
- 临床相关失血定义为>20 mL/kg。
- 证据等级为治疗性I级。
临床怎么用
- 原文结论为青少年特发性脊柱侧凸手术中使用TXA较安慰剂显著减少失血27%,未给出具体临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tranexamic acid (TXA) is an antifibrinolytic drug that reduces surgical blood loss. Evidence supporting its efficacy in surgery for adolescent idiopathic scoliosis is not robust. This trial was designed to validate the clinical efficacy of TXA in surgery for adolescent idiopathic scoliosis. METHODS: This institutional review board-approved prospective double-blinded trial involved 111 patients with adolescent idiopathic scoliosis who were randomized to receive either a placebo or TXA (50-mg/kg loading dose and 10-mg/kg/h infusion). Power analysis indicated that 50 patients per group would provide power to detect a >20% difference in blood loss. Two-way analysis of variance (ANOVA) was applied to compare blood loss rates (slopes) using the group-by-time interaction F test. RESULTS: The risk of clinically relevant blood loss (>20 mL/kg) was more than twice as high in the placebo group than in the TXA group (44% versus 21%, relative risk = 2.1, 95% confidence interval = 1.2 to 3.7). Compared with the placebo group, the TXA group had a 27% reduction in intraoperative blood loss, a significantly lower rate of intraoperative bleeding per hour (mean and standard deviation, 190 ± 73 versus 230 ± 80 mL, p = 0.01; F = 9.77, p < 0.001) and per fused spinal level (82 ± 32 versus 110 ± 40 mL, p < 0.001), less intraoperative blood loss (836 ± 373 versus 1,031 ± 484 mL, p = 0.02), and less postoperative bleeding (in the drain) (498 ± 228 versus 645 ± 318 mL, p = 0.009). Six patients who received a placebo and no patient who received TXA required an allogenic blood transfusion. No perioperative adverse events, including thromboembolic events or seizures, were observed. Three independent factors were predictive of blood loss: TXA administration, duration of surgery, and number of levels fused. Greater intraoperative blood loss was the only independent variable predictive of a longer hospital stay. CONCLUSIONS: Use of TXA in patients undergoing surgery for adolescent idiopathic scoliosis significantly reduced blood loss, by 27%, compared with that in the placebo group. The rate of intraoperative blood loss per hour and per level fused and the amount of postoperative blood loss were significantly lower in the TXA group. More placebo-treated patients received allogenic blood. Patients with greater intraoperative blood loss spent a longer time in the hospital. LEVEL OF EVIDENCE: Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.
引用
- Goobie SM, Zurakowski D, Glotzbecker MP, et al. Tranexamic Acid Is Efficacious at Decreasing the Rate of Blood Loss in Adolescent Scoliosis Surgery: A Randomized Placebo-Controlled Trial. J Bone Joint Surg Am. 2018. PMID: 30516625. doi:10.2106/JBJS.18.00314
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。